New cancer clinical trial: A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, With Cetuximab in Subjects With Advanced Solid Cancers

Published on: January 25, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share